Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ani Pharmaceuticals (ANIP) Debt Ratio (2017 - 2025)

Historic Debt Ratio for Ani Pharmaceuticals (ANIP) over the last 11 years, with Q3 2025 value amounting to 0.22.

  • Ani Pharmaceuticals' Debt Ratio fell 1061.97% to 0.22 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.22, marking a year-over-year decrease of 1061.97%. This contributed to the annual value of 0.25 for FY2024, which is 2451.91% down from last year.
  • Per Ani Pharmaceuticals' latest filing, its Debt Ratio stood at 0.22 for Q3 2025, which was down 1061.97% from 0.23 recorded in Q2 2025.
  • Ani Pharmaceuticals' Debt Ratio's 5-year high stood at 0.43 during Q3 2021, with a 5-year trough of 0.22 in Q3 2025.
  • For the 5-year period, Ani Pharmaceuticals' Debt Ratio averaged around 0.34, with its median value being 0.36 (2023).
  • As far as peak fluctuations go, Ani Pharmaceuticals' Debt Ratio soared by 567.38% in 2021, and later crashed by 2839.07% in 2024.
  • Quarter analysis of 5 years shows Ani Pharmaceuticals' Debt Ratio stood at 0.37 in 2021, then grew by 1.21% to 0.38 in 2022, then dropped by 12.86% to 0.33 in 2023, then decreased by 24.52% to 0.25 in 2024, then dropped by 10.37% to 0.22 in 2025.
  • Its last three reported values are 0.22 in Q3 2025, 0.23 for Q2 2025, and 0.24 during Q1 2025.